Reaction Details |
| Report a problem with these data |
Target | Neuromedin-K receptor |
---|
Ligand | BDBM280769 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Aequorin Assay with Human NK-3 Receptor |
---|
IC50 | 285±n/a nM |
---|
Citation | Hoveyda, H; Dutheuil, G; Fraser, G N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists US Patent US10836768 Publication Date 11/17/2020 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Neuromedin-K receptor |
---|
Name: | Neuromedin-K receptor |
Synonyms: | NK-3 receptor | NK-3R | NK3R | NK3R_HUMAN | NKR | Neurokinin 3 receptor | Neurokinin B receptor | Neurokinin-3 (NK-3) | Neuromedin-3 receptor (NK-3R) | Neuromedin-3 receptor (NK3) | Neuromedin-K receptor | Neuromedin-K receptor (NK-3 receptor) | Neuromedin-K receptor (NK3) | Neuromedin-K receptor(NK3R) | TAC3R | TACR3 | Tachykinin receptor 3 | Tachykinin receptor 3 (NK3) |
Type: | Enzyme |
Mol. Mass.: | 52221.96 |
Organism: | Homo sapiens (Human) |
Description: | P29371 |
Residue: | 465 |
Sequence: | MATLPAAETWIDGGGGVGADAVNLTASLAAGAATGAVETGWLQLLDQAGNLSSSPSALGL
PVASPAPSQPWANLTNQFVQPSWRIALWSLAYGVVVAVAVLGNLIVIWIILAHKRMRTVT
NYFLVNLAFSDASMAAFNTLVNFIYALHSEWYFGANYCRFQNFFPITAVFASIYSMTAIA
VDRYMAIIDPLKPRLSATATKIVIGSIWILAFLLAFPQCLYSKTKVMPGRTLCFVQWPEG
PKQHFTYHIIVIILVYCFPLLIMGITYTIVGITLWGGEIPGDTCDKYHEQLKAKRKVVKM
MIIVVMTFAICWLPYHIYFILTAIYQQLNRWKYIQQVYLASFWLAMSSTMYNPIIYCCLN
KRFRAGFKRAFRWCPFIKVSSYDELELKTTRFHPNRQSSMYTVTRMESMTVVFDPNDADT
TRSSRKKRATPRDPSFNGCSRRNSKSASATSSFISSPYTSVDEYS
|
|
|
BDBM280769 |
---|
n/a |
---|
Name | BDBM280769 |
Synonyms: | US10030025, Compound 45-2 | US10836768, Cpd no 45-1 | US11731974, Compound 45-1 | US9987274, Compound 45-1 |
Type | Small organic molecule |
Emp. Form. | C17H16F2N6O2 |
Mol. Mass. | 374.3447 |
SMILES | C[C@@H](F)c1noc(n1)-c1nnc2[C@@H](C)N(CCn12)C(=O)c1ccc(F)cc1 |r| |
Structure |
|